Reduced prostate branching morphogenesis in stromal fibroblast, but not in epithelial, estrogen receptor α knockout mice

Asian Journal of Andrology

Volumn 14, Issue 4, 2012, Pages 546-555

  Chen, Ming ^a   Yeh, Chiuan Ren ^a   Shyr, Chih Rong ^b   Lin, Hsiu Hsia ^a   Da, Jun ^a   Yeh, Shuyuan ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cre loxP; estrogen receptor; knockout; prostate; stromalepithelial interaction

Indexed keywords

BETA ACTIN; BONE MORPHOGENETIC PROTEIN 4; CALVASCULIN; CRE RECOMBINASE; ESTROGEN RECEPTOR ALPHA; FIBROBLAST GROWTH FACTOR 10; SOMATOMEDIN C; TESTOSTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; EPITHELIUM CELL; FIBROBLAST; IN VIVO STUDY; KNOCKOUT MOUSE; MALE FERTILITY; MORPHOGENESIS; MOUSE; NONHUMAN; PARACRINE SIGNALING; PROSTATE; PROTEIN FUNCTION; WILD TYPE;

ANIMALS; APOPTOSIS; BONE MORPHOGENETIC PROTEIN 4; EPITHELIAL CELLS; ESTROGEN RECEPTOR ALPHA; FERTILITY; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 7; FIBROBLASTS; GENE EXPRESSION; GENOTYPE; HOMEODOMAIN PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, KNOCKOUT; ORGAN SIZE; PROSTATE; PROSTATIC SECRETORY PROTEINS; RECEPTORS, ANDROGEN; SPERM COUNT; TESTOSTERONE; TRANSCRIPTION FACTORS;

EID: 84863708448     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2011.181     Document Type: Article

References (42)

1. Yatsenko AN, Roy A, Chen R, Ma L, Murthy LJ et al. Non-invasive genetic diagnosis of male infertility using spermatozoa RNA: KLHL10 mutations in oligozoospermic patients impair homodimerization. Hum Mol Genet 2006; 15: 3411-9.
2. Stahl PJ, Masson P, Mielnik A, Marean MB, Schlegel PN et al. A decade of experience emphasizes that testing for Y microdeletions is essential in American men with azoospermia and severe oligozoospermia. Fertil Steril 2010; 94: 1753-6.
3. Miyamoto T, Tsujimura A, Miyagawa Y, Koh E, Sakugawa N et al. A single nucleotide polymorphism in SPATA17 may be a genetic risk factor for Japanese patients with meiotic arrest. Asian J Androl 2009; 11: 623-8.
4. Sakugawa N, Miyamoto T, Tsujimura A, Koh E, Miyagawa Y et al. LMTK2 and PARP-2 gene polymorphism and azoospermia secondary to meiotic arrest. J Assist Reprod Genet 2009; 26: 545-52.
5. Miyamoto T, Tsujimura A, Miyagawa Y, Koh E, Namiki M et al. Single nucleotide polymorphism in the UBR2 gene may be a genetic risk factor for Japanese patients with azoospermia by meiotic arrest. J Assist Reprod Genet 2011; 28: 743-6.
6. Nasmyth K. Segregating sister genomes: the molecular biology of chromosome separation. Science 2002; 297: 559-65.
7. Fukuda T, Daniel K, Wojtasz L, Toth A, Hoog C. A novel mammalian HORMA domaincontaining protein, HORMAD1, preferentially associates with unsynapsed meiotic chromosomes. Exp Cell Res 2010; 316: 158-71.
8. Shin YH, Choi Y, Erdin SU, Yatsenko SA, Kloc M et al. Hormad1 mutation disrupts synaptonemal complex formation, recombination, and chromosome segregation in mammalian meiosis. PLos Genet 2010; 6: e1001190.
9. Ricke WA, McPherson SJ, Bianco JJ, Cunha GR, Wang Y et al. Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling. FASEB J 2008; 22: 1512-20.
10. Mao X, Fujiwara Y, Orkin SH. Improved reporter strain for monitoring Cre recombinasemediated DNA excisions in mice. Proc Natl Acad Sci USA 1999; 96: 5037-42.
11. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999; 21:70-1.
12. Chen M, Ni J, Zhang Y, Muyan M, Yeh S. ERAP75 functions as a coactivator to enhance estrogen receptor alpha transactivation in prostate stromal cells. Prostate 2008; 68: 1273-82.
13. Iwano M, Fischer A, Okada H, Plieth D, Xue C et al. Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts. Mol Ther 2001; 3: 149-59.
14. Iwano M, Plieth D, Danoff TM, Xue C, Okada H et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110: 341-50.
15. Strutz F, Okada H, Lo CW, Danoff T, Carone RL et al. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995; 130: 393-405.
16. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N et al. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004; 303: 848-51.
17. Sugimura Y, Cunha GR, Donjacour AA. Morphogenesis of ductal networks in the mouse prostate. Biol Reprod 1986; 34: 961-71.
18. Niu Y, Altuwaijri S, Yeh S, Lai KP, Yu S et al. Targeting the stromal androgen receptor in primary prostate tumors at earlier stages. Proc Natl Acad Sci USA 2008; 105: 12188-93.
19. Niu Y, Altuwaijri S, Lai KP, Wu CT, Ricke WA et al. Androgen receptor is a tumor suppressor and proliferator in prostate cancer. Proc Natl Acad Sci USA 2008; 105: 12182-7.
20. Yu S, Yeh CR, Niu Y, Chang HC, Tsai YC et al. Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts. Prostate 2011; 72: 437-49.
21. Yu S, Zhang C, Lin CC, Niu Y, Lai KP et al. Altered prostate epithelial development and IGF-1 signal in mice lacking the androgen receptor in stromal smooth muscle cells. Prostate 2011; 71: 517-24.
22. Weihua Z, Makela S, Andersson LC, Salmi S, Saji S et al. A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc Natl Acad Sci USA 2001; 98: 6330-5.
23. McPherson SJ, Ellem SJ, Simpson ER, Patchev V, Fritzemeier KH et al Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia. Endocrinology 2007; 148: 566-74.
24. Wu X, Wu J, Huang J, Powell WC, Zhang J et al. Generation of a prostate epithelial cellspecific Cre transgenic mouse model for tissue-specific gene ablation. Mech Dev 2001; 101: 61-9.
25. Wu CT, Altuwaijri S, Ricke WA, Huang SP, Yeh S et al. Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor. Proc Natl Acad Sci USA 2007; 104: 12679-84.
26. Wang S, Garcia AJ, Wu M, Lawson DA, Witte ON et al. Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. Proc Natl Acad Sci USA 2006; 103: 1480-5.
27. Marker PC, Donjacour AA, Dahiya R, Cunha GR. Hormonal, cellular, and molecular control of prostatic development. Dev Biol 2003; 253: 165-74.
28. Lamm ML, Podlasek CA, Barnett DH, Lee J, Clemens JQ et al. Mesenchymal factor bone morphogenetic protein 4 restricts ductal budding and branching morphogenesis in the developing prostate. Dev Biol 2001; 232: 301-14.
29. Grishina IB, Kim SY, Ferrara C, Makarenkova HP, Walden PD. BMP7 inhibits branching morphogenesis in the prostate gland and interferes with Notch signaling. Dev Biol 2005; 288: 334-47.
30. King KJ, Nicholson HD, Assinder SJ. Effect of increasing ratio of estrogen: androgen on proliferation of normal human prostate stromal and epithelial cells, and the malignant cell line LNCaP. Prostate 2006; 66: 105-14.
31. Chen M, Yeh CR, Chang HC, Vitkus S, Wen XQ et al. Loss of epithelial oestrogen receptor a inhibits oestrogen-stimulated prostate proliferation and squamous metaplasia via in vivo tissue selective knockout models. J Pathol 2012; 226: 17-27.
32. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P et al. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 2000; 127: 4277-91.
33. Antal MC, Krust A, Chambon P, Mark M. Sterility and absence of histopathological defects in nonreproductive organs of a mouse ERbeta-null mutant. Proc Natl Acad Sci USA 2008; 105: 2433-8.
34. Trimboli AJ, Cantemir-Stone CZ, Li F, Wallace JA, Merchant A et al. Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 2009; 461: 1084-91.
35. Timms BG, Petersen SL, vom Saal FS. Prostate gland growth during development is stimulated in both male and female rat fetuses by intrauterine proximity to female fetuses. J Urol 1999; 161: 1694-701
36. vomSaal FS, Timms BG,MontanoMM, Palanza P, Thayer KA et al. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci USA 1997; 94: 2056-61.
37. Labrie F. Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA. Endocr Relat Cancer 2006; 13: 335-55.
38. Hayward SW, Cunha GR. The prostate: development and physiology. Radiol Clin North Am 2000; 38: 1-14.
39. Thomsen MK, Butler CM, Shen MM, Swain A. Sox9 is required for prostate development. Dev Biol 2008; 316: 302-11.
40. Wen F, Cecena G,Munoz-Ritchie V, Fuchs E, Chambon P et al. Expression of conditional cre recombinase in epithelial tissues of transgenic mice. Genesis 2003; 35: 100-6.
41. Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der ValkMet al. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 00129: 418-25.
42. Wolfe A, Divall S, Singh SP, Nikrodhanond AA, Baria AT et al. Temporal and spatial regulation of CRE recombinase expression in gonadotrophin-releasing hormone neurones in the mouse. J Neuroendocrinol 2008; 20: 909-16.